Wellbutrin (Bupropion): Uses, Side Effects, Dosing, and How it Works
Author:
Blossom Editorial
Mar 13, 2026
Wellbutrin (bupropion) is a unique antidepressant that works differently from the more commonly known SSRIs like Lexapro or Prozac. Rather than targeting serotonin, bupropion mainly affects dopamine and norepinephrine — neurotransmitters tied to motivation, energy, and focus. This distinct mechanism makes Wellbutrin a valuable option for people who haven't responded well to SSRIs, or who want to avoid certain side effects commonly associated with that drug class.
Whether you are newly prescribed Wellbutrin or simply want to understand your options, this guide covers the essential information about how it works, what it treats, what to expect, and when to speak with a healthcare provider.
Key Takeaways
Different mechanism than SSRIs: Wellbutrin is a norepinephrine-dopamine reuptake inhibitor (NDRI). It does not significantly affect serotonin, which means it typically does not cause the sexual side effects or weight gain commonly associated with SSRIs.
Multiple FDA-approved uses: Bupropion is FDA-approved for major depressive disorder (MDD), seasonal affective disorder (SAD), and smoking cessation. It is also widely used off-label for ADHD, bipolar depression, and antidepressant-induced sexual dysfunction.
Seizure risk requires attention: At its recommended dose, bupropion carries a small but real risk of seizures. Staying within prescribed dose limits and informing your provider about your medical history is essential for safe use.
What is Wellbutrin (Bupropion)?
Wellbutrin is the brand name for bupropion hydrochloride, an antidepressant classified as a norepinephrine-dopamine reuptake inhibitor (NDRI). It is sometimes called an "atypical" antidepressant because it works differently from antidepressants in the SSRI and SNRI categories that dominate antidepressant prescribing.
Bupropion works by inhibiting the transporters that reabsorb dopamine and norepinephrine from the synaptic cleft — the space between nerve cells. By blocking reuptake, it increases the availability of both neurotransmitters in the brain, producing antidepressant effects, potentially improving energy, motivation, and concentration.
Bupropion is not known to impact serotonin levels in the brain, which is the primary mechanism of action of SSRI antidepressants.
Bupropion is available in three main formulations: immediate-release (Wellbutrin), sustained-release (Wellbutrin SR), and extended-release (Wellbutrin XL). The SR formulation is typically taken twice daily, while the XL version is taken once daily. The SR and XL formulations are the most commonly prescribed forms today. The smoking cessation variant of bupropion is marketed separately under the brand name Zyban.
What Does Wellbutrin Treat?
FDA-Approved Indications
Major Depressive Disorder (MDD): Wellbutrin was approved for MDD in 1985, making it one of the longer-standing antidepressants on the market. Clinicians sometimes prescribe bupropion for people experiencing low energy, hypersomnia (excessive sleepiness), or difficulty concentrating alongside their depression.
Seasonal Affective Disorder (SAD): Wellbutrin XL received FDA approval in 2006 for SAD, a type of depression that follows a seasonal pattern and typically peaks in winter months. Treatment usually begins in autumn, a few months before symptoms appear.
Smoking Cessation (Zyban): Bupropion under the name Zyban is FDA-approved to help people quit smoking by reducing nicotine cravings and withdrawal symptoms.
Common Off-Label Uses
Bupropion is also widely used off-label for several other conditions, based on effectiveness:
ADHD (attention-deficit/hyperactivity disorder): bupropion is often prescribed as a non-stimulant medication for ADHD, particularly when stimulant medications are not effective or produce side effects. Current research, however, is not conclusive regarding bupropion’s effectiveness compared to stimulants for ADHD.
Bipolar depression: as an adjunct to mood stabilizers, although research on its safety and efficacy has delivered mixed results so far; by itself, bupropion is not FDA-approved for bipolar disorder and has a risk of triggering mania.
SSRI-induced sexual dysfunction: to counteract sexual side effects from other antidepressants
Weight management: as part of the combination drug naltrexone/bupropion (Contrave). It was FDA-approved in 2025 for chronic weight management in patients with obesity who also have at least one weight-induced comorbid condition, such as hypertension or diabetes.
How Wellbutrin Differs From SSRIs
One of the most significant clinical distinctions of bupropion lies in what it does not do: it does not substantially affect serotonin. This has important practical consequences for patients:
Low risk of SSRI sexual side effects: Sexual dysfunction, including decreased libido, difficulty with orgasm, and ejaculatory problems, is among the most common complaints with SSRIs. Research shows that the odds of having sexual dysfunction with SSRIs are four to six times higher than with bupropion. Bupropion is sometimes added to SSRI regimens specifically to address SSRI-induced sexual dysfunction.
Less likely to cause weight gain: Many people are concerned about weight changes with antidepressants. Clinical evidence and prescriber experience suggest bupropion is among the least likely antidepressants to cause weight gain, and some patients experience modest weight loss.
More activating, less sedating: Rather than causing drowsiness, bupropion tends to have a slightly stimulating quality, which can help people with fatigue and low motivation — but may also worsen insomnia in some individuals.
Wellbutrin Dosing
According to the FDA, Wellbutrin dosing varies by formulation:
Wellbutrin (immediate-release): Starting dose of 100 mg twice daily, may increase to 100 mg three times daily after three days. The maximum dose is 450 mg/day divided between three doses.
Wellbutrin SR (sustained-release): Starting dose of 150 mg once daily, may increase to 150 mg twice daily after three days. The maximum dose is 400 mg/day, divided between two doses, only when 300 mg/day doesn’t produce a response.
Wellbutrin XL (extended-release): Starting dose of 150 mg once daily, may increase to 300 mg/day after four days.
Doses should always be increased gradually to minimize seizure risk. Dosing schedules depend on formulation. Immediate-release doses are divided throughout the day, while extended-release forms may be taken once daily.
Note: Any dosage-related information provided about bupropion is intended for general educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a licensed healthcare provider before starting, stopping, or changing any medication.
Side Effects of Wellbutrin
Most people tolerate bupropion reasonably well. Side effects tend to be dose-dependent and often improve as the body adjusts in the first few weeks. Common side effects include:
Dry mouth
Headache
Nausea
Insomnia or difficulty falling asleep
Agitation or restlessness
Constipation
Increased sweating
Dizziness
Tremor
Because bupropion has a mild stimulant-like quality, it can occasionally increase anxiety, irritability, or heart rate — particularly at higher doses or when first starting treatment. Taking it earlier in the day and starting at a lower dose can help minimize these effects.
Important Safety Information and Warnings
Seizure Risk
One of the most important safety considerations with bupropion is its dose-related risk of seizures. According to FDA prescribing information, the approximate incidence of seizures with bupropion at recommended doses is 0.4% (4 in 1,000 patients). This risk increases significantly at higher doses, which is why the maximum daily dose should never be exceeded.
Bupropion should not be used by people with a history of seizure disorders, eating disorders (anorexia or bulimia nervosa), or those undergoing abrupt withdrawal from alcohol or benzodiazepines. Always inform your prescriber about your complete medical history before starting this medication.
Some medicines may decrease the seizure threshold of bupropion with concomitant use. This includes antidepressants, antipsychotics, antiepileptics, theophylline, and systemic corticosteroids. Dosage of such medicines must also be carefully considered to avoid seizure risk.
Black Box Warning: Suicidal Thoughts
Like all antidepressants, bupropion carries an FDA black box warning about the risk of increased suicidal thoughts and behaviors in children, adolescents, and young adults under 25, particularly in the early weeks of treatment or when doses are adjusted. Close monitoring is especially important during this period.
Blood Pressure
Bupropion can increase blood pressure in some people. Monitoring blood pressure before and during treatment is generally recommended, particularly in those with pre-existing hypertension.
Drug Interactions
Bupropion interacts with several medications that are important to know about. It can inhibit the CYP2D6 enzyme, meaning it may increase the blood levels of other medications metabolized by this pathway — including certain antidepressants (like desipramine), antipsychotics, and beta-blockers. It also carries interaction risks with:
MAOIs: must not be taken within 14 days of each other due to severe reaction risk
Alcohol: can lower the seizure threshold and is not recommended
Stimulants and cocaine: increase seizure risk
Nicotine patches: when combined with bupropion for smoking cessation, increased blood pressure monitoring is warranted
Tell your prescriber about every medication, supplement, and substance you use before starting Wellbutrin.
How Long Does Wellbutrin Take to Work?
As with most antidepressants, the full effects of bupropion take time. Some patients notice early improvements in energy, sleep, or concentration within the first 1–2 weeks. However, meaningful changes in depressed mood and anxiety typically take 4–6 weeks at a therapeutic dose.
It is important to remember that, like with most antidepressants, the side effects are usually the first to appear. Avoid abruptly stopping bupropion to prevent discontinuation symptoms. If you are not feeling improvement after 6–8 weeks at an appropriate dose, contact your prescriber. They may recommend a dose adjustment or a different approach to treatment.
Is Wellbutrin Right for You?
Wellbutrin may be a particularly good fit for individuals who:
Have not responded to SSRIs or experienced intolerable SSRI side effects
Want to avoid weight gain or sexual side effects
Struggle primarily with low energy, motivation, or concentration
Have a co-occurring smoking habit they want to address
Have seasonal affective disorder with prominent winter depression
However, it may not be the best choice for individuals with a history of seizures, eating disorders, or those who are highly prone to anxiety and restlessness. A psychiatrist can help you evaluate your full clinical picture and decide whether bupropion is right for your situation.
Accessing Psychiatric Care
Getting started with Wellbutrin requires a prescription and ongoing monitoring from a licensed healthcare provider, typically a psychiatrist or primary care physician with mental health expertise.
Blossom Health connects patients with board-certified psychiatrists through virtual, in-network appointments that can often be scheduled within days.
Medical Disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you may have regarding a medical condition or medication. If you are experiencing a mental health crisis, call or text 988 (Suicide and Crisis Lifeline) or 911.
Sources
Huecker MR, Smiley A, Saadabadi A. Bupropion. [Updated 2024 Sep 2]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470212/
Stahl, S. M., Pradko, J. F., Haight, B. R., Modell, J. G., Rockett, C. B., & Learned-Coughlin, S. (2004). A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor. Primary care companion to the Journal of clinical psychiatry, 6(4), 159–166. https://pmc.ncbi.nlm.nih.gov/articles/PMC514842/
U.S. Food and Drug Administration. (2017). Wellbutrin (bupropion hydrochloride) tablets: Prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018644s052lbl.pdf
U.S. Food and Drug Administration. (2025). Wellbutrin SR (bupropion hydrochloride) sustained-release tablets: Prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020358s070lbl.pdf
U.S. Food and Drug Administration. (2024). Wellbutrin XL (bupropion hydrochloride extended-release) tablets: Prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021515s046lbl.pdf
National Institute of Mental Health. (2024, December). Depression. U.S. Department of Health and Human Services, National Institutes of Health. https://www.nimh.nih.gov/health/topics/depression
Ng Q. X. (2017). A Systematic Review of the Use of Bupropion for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Journal of child and adolescent psychopharmacology, 27(2), 112–116. https://pubmed.ncbi.nlm.nih.gov/27813651/
Clark, A., Tate, B., Urban, B., Schroeder, R., Gennuso, S., Ahmadzadeh, S., McGregor, D., Girma, B., Shekoohi, S., & Kaye, A. D. (2023). Bupropion mediated effects on depression, attention deficit hyperactivity disorder, and smoking cessation. Health Psychology Research, 11, 81043. https://healthpr.org/journal/HPR/11/1/10.52965/001c.81043
Currax Pharmaceuticals LLC. (2025). Contrave (naltrexone hydrochloride and bupropion hydrochloride) extended-release tablets [Package insert]. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/200063s024s026lbl.pdf
Clayton, A. H., Pradko, J. F., Croft, H. A., Montano, C. B., Leadbetter, R. A., Bolden-Watson, C., Bass, K. I., Donahue, R. M., Jamerson, B. D., & Metz, A. (2002). Prevalence of sexual dysfunction among newer antidepressants. The Journal of clinical psychiatry, 63(4), 357–366. https://pubmed.ncbi.nlm.nih.gov/12000211/
Safarinejad, M.R. (2010).The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double-blind placebo-controlled and randomized study. BJU International, 106(6), 840-847. https://bjui-journals.onlinelibrary.wiley.com/doi/10.1111/j.1464-410X.2009.09154.x
Mouawad, M., Nabipur, L., & Agrawal, D. K. (2025). Impact of Antidepressants on Weight Gain: Underlying Mechanisms and Mitigation Strategies. Archives of clinical and biomedical research, 9(3), 183–195.https://pmc.ncbi.nlm.nih.gov/articles/PMC12121960
DrugBank. (n.d.). Bupropion. Retrieved March 10, 2026, from https://go.drugbank.com/drugs/DB01156.
Mayo Clinic. (2026, February 1). Bupropion (oral route). https://www.mayoclinic.org/drugs-supplements/bupropion-oral-route/description/drg-20062478
Kotlyar, M., Brauer, L. H., Tracy, T. S., Hatsukami, D. K., Harris, J., Bronars, C. A., & Adson, D. E. (2005). Inhibition of CYP2D6 activity by bupropion. Journal of clinical psychopharmacology, 25(3), 226–229. https://pubmed.ncbi.nlm.nih.gov/15876900/
American Society of Health-System Pharmacists. (2025, November 15). Bupropion. MedlinePlus. https://medlineplus.gov/druginfo/meds/a695033.html
National Alliance on Mental Illness. (n.d.). Bupropion (Wellbutrin). Retrieved March 10, 2026, from https://www.nami.org/about-mental-illness/treatments/mental-health-medications/types-of-medication/bupropion-wellbutrin/
